NOBEL BIOCARE SERVICES AG V. INSTRADENT USA, INC.
- Sep 24 2018 |
- Category: CAFC Updates
Nobel appeals from the decision of the PTAB in an inter partes review (“IPR”) holding certain claims of U.S. Patent 8,714,977 directed to dental implants unpatentable. Addressing issues including whether a particular prior art reference (the ABT Catalog) was publicly accessible prior to the critical date, the sufficiency of the corroboration of the testimony, and the construction of the term “frustoconical” in the claims, the CAFC finds that the Board did not err in its anticipation finding, and affirms.